Tumor angiogenesis at baseline identified by (18)F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent c...

por Wei, Yuchun, Qin, Xueting, Liu, Xiaoli, Zheng, Jinsong, Luan, Xiaohui, Zhou, Yue, Yu, Jinming, Yuan, Shuanghu
Publicado 2022

A Preclinical Study of an (125)I-Labeled PSMA Ligand for Prostate-Cancer Puncture

por Luan, Xiaohui, Zhou, Haoxi, Chen, Yimin, Zhang, Xiaojun, Cui, Mengchao, Chen, Kuang, Xu, Xiaodan, Zhang, Jinming, Xu, Baixuan
Publicado 2022

Can (18)F-PSMA-7Q PET/CT replace prostate biopsy for the diagnosis of prostate cancer?—A single-center retrospective study

por Liu, Yachao, Niu, Shaoxi, Luan, Xiaohui, Zhang, Xiaojun, Liu, Jiajin, Zhang, Jinming, Wang, Ruimin, Xu, Baixuan, Zhang, Xu
Publicado 2023

(18)F-alfatide PET/CT may predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer

por Luan, Xiaohui, Huang, Yong, Gao, Song, Sun, Xiaorong, Wang, Suzhen, Ma, Li, Teng, Xuepeng, Lu, Hong, Yu, Jinming, Yuan, Shuanghu
Publicado 2016

(18)F-RGD PET/CT imaging reveals characteristics of angiogenesis in non-small cell lung cancer

por Li, Li, Zhao, Wei, Sun, Xiaorong, Liu, Ning, Zhou, Yue, Luan, Xiaohui, Gao, Song, Zhao, Shuqiang, Yu, Jinming, Yuan, Shuanghu
Publicado 2020

Multiparameter diagnostic model based on (18)F-FDG PET metabolic parameters and clinical variables can differentiate nonmetastatic gallbladder cancer and cholecystitis

por Li, Can, Luan, Xiaohui, Bi, Xiao, Chen, Shengxin, Pan, Yue, Zhang, Jingfeng, Han, Yun, Xu, Xiaodan, Wang, Guanyun, Xu, Baixuan
Publicado 2023

The role of (18)F−FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy

por Wang, Guanyun, Zhang, Wenwen, Luan, Xiaohui, Wang, Zhanbo, Liu, Jiajin, Xu, Xiaodan, Zhang, Jinming, Xu, Baixuan, Lu, Shichun, Wang, Ruimin, Ma, Guangyu
Publicado 2023

Corrigendum: The role of 18F−FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion...

por Wang, Guanyun, Zhang, Wenwen, Luan, Xiaohui, Wang, Zhanbo, Liu, Jiajin, Xu, Xiaodan, Zhang, Jinming, Xu, Baixuan, Lu, Shichun, Wang, Ruimin, Ma, Guangyu
Publicado 2023

Multiparameter diagnostic model based on (18)F-FDG positron emission tomography and serological examination for differentiating focal autoimmune pancreatitis from pancreatic ductal...

por Wang, Guanyun, Du, Lei, Lu, Xia, Chen, Shengxin, Bi, Xiao, Zhang, Mingyu, Luan, Xiaohui, Xu, Xiaodan, Zhang, Zhuochao, Xu, Baixuan, Yang, Jigang
Publicado 2023

Pretreatment Metabolic Parameters Measured by (18)F-FDG PET to Predict the Pathological Treatment Response of HCC Patients Treated With PD-1 Inhibitors and Lenvatinib as a Conversi...

por Wang, Guanyun, Zhang, Wenwen, Chen, Jiaxin, Luan, Xiaohui, Wang, Zhanbo, Wang, Yanmei, Xu, Xiaodan, Yao, Shulin, Guan, Zhiwei, Tian, Jiahe, Lu, Shichun, Xu, Baixuan, Ma, Guangyu
Publicado 2022